Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 536, doi. 10.1038/onc.2013.510
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2014 AND VI 33 AND IP 4
Results: 15
1
2
CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 504, doi. 10.1038/onc.2012.602
- By:
- Publication type:
- Article
3
Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 461, doi. 10.1038/onc.2012.608
- By:
- Publication type:
- Article
4
Oncogenic K-Ras requires activation for enhanced activity.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 532, doi. 10.1038/onc.2012.619
- By:
- Publication type:
- Article
5
A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 411, doi. 10.1038/onc.2012.607
- By:
- Publication type:
- Article
6
DMAP1 is an essential regulator of ATM activity and function.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 525, doi. 10.1038/onc.2012.597
- By:
- Publication type:
- Article
7
Ink4a/Arf<sup>−/−</sup> and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f<sup>−</sup> quiescent cells.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 440, doi. 10.1038/onc.2012.609
- By:
- Publication type:
- Article
8
Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 429, doi. 10.1038/onc.2012.612
- By:
- Publication type:
- Article
9
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 421, doi. 10.1038/onc.2012.605
- By:
- Publication type:
- Article
10
Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 474, doi. 10.1038/onc.2012.606
- By:
- Publication type:
- Article
11
Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 495, doi. 10.1038/onc.2012.603
- By:
- Publication type:
- Article
12
Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 449, doi. 10.1038/onc.2012.618
- By:
- Publication type:
- Article
13
The function of ORAOV1/LTO1, a gene that is overexpressed frequently in cancer: essential roles in the function and biogenesis of the ribosome.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 484, doi. 10.1038/onc.2012.604
- By:
- Publication type:
- Article
14
Myocyte enhancer factor 2C in hematopoiesis and leukemia.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 403, doi. 10.1038/onc.2013.56
- By:
- Publication type:
- Article
15
Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
- Published in:
- Oncogene, 2014, v. 33, n. 4, p. 514, doi. 10.1038/onc.2012.598
- By:
- Publication type:
- Article